28 Participants NeededMy employer runs this trial

Itraconazole and MK-2828 for Drug Interaction Study

TF
Overseen ByToll Free Number
Age: 18 - 65
Sex: Any
Trial Phase: Phase 1
Sponsor: Merck Sharp & Dohme LLC
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The main goals of this study are:

* To learn what happens to one dose of MK-2828 in a healthy person's body over time when it is taken with itraconzole

* To learn what happens to one dose of midazolam in a healthy person's body over time when it is taken with MK-2828

Researchers want to learn if the levels of MK-2828 in the body are about the same when MK-2828 is taken with itraconazole as when it is taken alone. They also want to know if taking MK-2828 more than once affects how much midazolam is in the body after a single dose.

Who Is on the Research Team?

MD

Medical Director

Principal Investigator

Merck Sharp & Dohme LLC

Are You a Good Fit for This Trial?

Inclusion Criteria

\- Participant is in good health

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Part 1: Itraconazole Treatment

Participants receive multiple oral doses of Itraconazole with a single oral dose of MK-2828

Approximately 12 days
Multiple visits for blood sampling

Part 2: Midazolam Treatment

Participants receive multiple oral doses of MK-2828 with a single oral dose of midazolam

Approximately 9 days
Multiple visits for blood sampling

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Itraconazole
  • Midazolam
  • MK-2828

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Part 2: MidazolamExperimental Treatment2 Interventions
Group II: Part 1: ItraconazoleExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Merck Sharp & Dohme LLC

Lead Sponsor

Trials
4,096
Recruited
5,232,000+
Chirfi Guindo profile image

Chirfi Guindo

Merck Sharp & Dohme LLC

Chief Marketing Officer since 2022

Degree in Engineering from Ecole Centrale de Paris, MBA from New York University Stern School of Business

Robert M. Davis profile image

Robert M. Davis

Merck Sharp & Dohme LLC

Chief Executive Officer since 2021

JD from Northwestern University Pritzker School of Law, MBA from Northwestern University Kellogg Graduate School of Management, Bachelor's in Finance from Miami University